tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joon Lee, 188 are a BUY (89.95%), 20 are a HOLD (9.57%), 1 are a SELL (0.48%).
Analyst Joon Lee, currently employed at TRUIST, carries an average stock price target met ratio of 50.37% that have a potential upside of 63.76% achieved within 252 days.
Joon Lee’s has documented 397 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CORT, Corcept Therapeutics at 18-Aug-2026.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
9 months 28 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
10 months 16 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
10 months 17 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 1 months 1 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 3 months 30 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
Which stock is Joon Lee most bullish on?
Which stock is Joon Lee most reserved on?
What Year was the first public recommendation made by Joon Lee?
